Right trisegmentectomy for hepatic neoplasms by Starzl, TE et al.
RIGHT TRISEGMENTECTOMY FOR HEPATIC NEOPLASMS 
Thomas E. Starzl, M.D., F.A.C.S., Lawrence J. Koep, M.D., 
Richard WeillII, M.D., F.A.C.S., John R. Lilly, M.D., F.A.C.S., Denver, Colorado, 
Charles W. Putnam, M.D., Tucson, Arizona, and J. Antonio Aldrete, M.D., Denver, Colorado 
RIOHT trisegmentectomy or extended right hepa-
tic lobectomy involves removal of the true right 
lobe of the liver plus the medial segment of the 
left lobe, leaving behind the variable 10 to 25 per 
cent of hepatic tissue that lies to the left of the fal-
ciform ligament. The operation was first per-
formed almost 30 years ago by Wangensteen 
(27), Lortat-Jacob and Robert (17) and Quat-
tlebaum (22), but until recently, its forbidding 
mortality prevented wide use. 
In 1975, we described in detail a safe tech-
nique of right trisegmentectomy (23). We report 
here an evaluation of the early and later results 
in 30 patients who had this operation for 26 
primary or metastatic malignant tumors and for 
four nonmalignant lesions. In addition, a modi-
fication from our original technique will be men-
tioned that has been particularly usdul for bulky 
superior and posterior hepatic tumors including 
those that invade the diaphragm. 
METHODS 
Thirty patients had trisegmentectomy. Nine 
pediatric patients had a mean age of 10.3±4.9 
S.D. years, a range of two to 16 years. Five were 
girls and four were boys. The 21 adults had a 
mean age of 51.1 ± 16.2 S.D. years, a range of 19 
to 74 years. Excluding the three adult women 
with benign hepatic lesions, the average age was 
55.1 ± 13.4 S.D. years. Thirteen of the adults 
were women and eight were men. Many of the 
patients who were referred for consideration of 
tt'ansplantation had been judged at other hospi-
tals to have unresectable tumors. Fifteen of the 
patients had undergone at least one exploratory 
laparotomy before referral. 
The histopathologic diagnoses are listed in 
Table I. There were four nonmalignant lesions, 
three adenomas and one focal nodular hyper-
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plasia. Three were in adults. One adenoma was 
in a 16 year old girl. 
Hepatomas were the most common of the 
primary hepatic malignant lesions (Table I). 
One of these, which was undifferentiated, was 
thought by some local and consulting pa-
thologists to be a sarcoma; this divided opinion 
was never reconciled. 
The conditions varied with hepatic resection 
for metastatic lesions. The most common local-
ized hepatic metastases were colorectal in origin 
(Table II). Resection of the primary colonic or 
rectal tumor had been done 12 to 18 months ear-
lier. The patient with neuroblastoma had simul-
taneous trisegmentectomy, right adrenalectomy 
and excision of a right retroperitoneal mass. 
Lymph nodes in the portal triad contained neuro-
blastoma. The tumor was considered Stage IV, 
by the criteria of Evans and associates (6). The 
tissue diagnoses in patients with glucagonoma 
and metastatic squamous cell carcinoma of the 
cervix were first made from the study of the 
hepatic specimen. In the first instance, a primary 
pancreatic tumor could never be found, even at 
autopsy, and in the second, the uterine cervical 
primary tumor was later treated with irradiation 
followed by hysterectomy and pelvic node dissec-
tion. The woman with carcinoma of the gallblad-
der had trisegmentectomy one month after chol-
ecystectomy. A 1.5 centimeter recurrence was 
found in the fossa of the gallbladder of the resect-
ed hepatic specimen. Three of the 30 patients had 
cirrhosis with one example each of mild, moder-
ate and severe. 
SUROICAL TECHNIQUE 
Trisegmentectomy was usually performed as 
described before (23). The principles were dis-
section and division of the hilar strictures enter-
ing the proposed specimen, division and suture 
closure or ligation of the hepatic veins leaving the 
specimen and a splitting of the hepatic paren-
chyma exactly along the intersegmental plane. 
The remaining lateral segment has been shown 
by Buerk and collaborators (4) to accommodate 
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FlO. 1. Control of right hepatic vein from within the liver. I. y.c.,lnferior vena cava. 
total portal blood flow without an increase in 
portal pressure. 
A modification omitting preliminary outflow 
control was useful or even essential for bulky 
tumors that were posteriorly or superiorly locat-
ed. After ligating the hilar structures, cleavage of 
the liver was carried out in the plane of the fal-
ciform ligament. The right hepatic vein was ap-
proached, cross clamped, divided and closed with 
suture from within the split parenchyma, as il-
lustrated in Figure 1. When tumor had invaded 
the diaphragm, diaphragmatic excision could be 
carried out as the last step in excision of the 
specimen. 
In one such patient, it was found at the last 
moment that the tumor had invaded the vena 
cava and left hepatic vein. These structures were 
excised. A reversed vena caval-iliac hemograft 
was used to replace the entire retrohepatic vena 
cava, and one of the iliac veins was anastomosed 
to a centrally located hepatic vein of the hepatic 
fragment (Fig. 2). 
Clamps, such as those described by Lin (15) 
and Storm and Longmire (25) for temporary 
hemostasis of the raw surface of the liver were 
not used. Operative transfusions averaged about 
2,500 milliliters for adults and less for children. 
Fresh blood, blood products and clot promoting 
pharmacologic agents were not used. Massive 
drainage was provided by leaving part of the in-
cision open and by filling the wound base with 
soft rubber drains (23). 
POSTOPERATIVE CARE 
Broad spectrum antibiotics which were begun 
12 hours before operation were continued for 
three or four days. The drains were removed in 
two to five days, and irrigations of the cavity done 
once or twice daily were begun with normal saline 
solution to which antibiotics were sometimes 
added. The wounds were allowed to heal from 
the depths. This required several weeks. Filling 
in of the hepatic fossa by regenerating the liver 
was a factor in shortening the time of wound 
healing. 
Standard postoperative care was given includ-
ing prolonged support of ventilation in some in-
stances. Specific methods to prevent or amelio-
rate hepatic failure were not ordinarily necessary. 
All of the patients became jaundiced postopera-
tively with high bilirubin levels of 4 to 30 milli-
grams per cent. The icterus reached a peak within 
a few days and receded progressively thereafter 
in all but one of the operative survivors. Other 
abnormalities in liver function were equally 
transient. Rises in serum transaminase levels 
were almost always minor, indicating that little 
damage had been inflicted on the residual (rag-
ment. 
ADJUVANT THERAPY 
Nine of the 26 patients with malignant disease 
received no treatment of the hepatic lesion other 
than resection. They were 50 to 74 years old, 
with an average age of 63 years. They declined 
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TABLE I.-INDICATIONS fOR AND RESULTS AfTER TRISEGMENTECTOMY WITH FOLLOW·UP STUDY TO 
1 APRIL, 1979 
Diapons 
~ni"I .................................. . 
e~paloma ............................... . 
S&rCIDInA ••.••.••••.•••..•••.••••.••••.••.. 
SqUamoul cdl carcinoma, C)"t •••...••.••••••• 
CholanJioc.utinom. ....................... . 
Localized ~ua ....................... . 
Total ........•.•......................... 
"Lata- ... tho __ all due to ~K F' ........ in~____ 
No. 01 OprTol .. " 
potlenls de"'" 
4 0 
14 I 
3 0 
1 0 
1 0 
7 0 
30 1 
funher treatment or were considered to be too 
frail to receive it. Some who are still in the early 
postoperative period may become candidates for 
delayed chemotherapy. Two patients, one pa-
tient with squamous cell carcinoma in a cyst and 
the other with neuroblastoma, received 3,000 
rads local irradiation plus multiple agent chemo-
therapy. 
In 14 other patients, chemotherapy was varia-
ble and planned according to the histopathologic 
diagnosis. Initially, the most common treatment 
for hepatomas was cyclophosphamide, 5-fluor-
ouracil and vincristine, as described by Holton 
and co-workers (11). This was followed with 
adriamycin if necessary for recurrences. The he-
terogeneity of the constituents, dosages and tim-
ing of adjuvant therapeutic protocols precluded 
conclusions about effectiveness beyond the obser-
vation that long term survival was obtained with-
out, as well as with, adjuvant therapeutic treat-
ment . 
When used, adjuvant treatment was begun 
only after recovery from the surgical procedure 
seemed assured. In most of the patients with 
localized metastases, the previously used chemo-
therapy was resumed. The time postoperatively 
usually ranged from a few days to several weeks. 
The stage of regeneration was not taken into ac-
count. The assumption was made that, once in 
full motion, the regeneration process would not 
be halted or seriously inhibited by irradiation or 
chemotherapy. 
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Mortality. There was one operative death, 3.3 
per cent, out of the 30 patients who underwent 
resections. This patient was a woman who re-
quired a reversed vena caval and iliac homograft 
to replace the excised left hepatic vein and retro-
hepatic vena cava. Hepatic venous drainage for 
the lateral segment was successfully provided 
(Fig. 2). Her initial course was satisfactory, but 
after ten days, the serum transaminase concen-
trations rose to extremely high levels. Hepatic 
insufficiency developed, and she died 20 days 
postoperatively. At autopsy, the celiac axis was 
occluded by fresh thrombosis that may have been 
initiated by selective arteriography one week 
preoperatively. The thrombosis was far from the 
field of 'operative dissecti~nI and the liver frag-
ment had extensive necrosis. 
Morbidity. One of the 30 patients required re-
exploration on the first postoperative night to 
control hemorrhage from the raw liver surface. 
Four of the 30 patients had abscesses develop in 
the hepatic fossa or right subhepatic space. These 
were drained by reopening the drain tracts which 
had closed prematurely at, or near, the anterior 
body wall. Two patients required secondary clo-
sureor the incisional gaps left fordrainage. through 
which bowel herniation occurred. Minor bile 
leaks through the drain site were common, but 
these all closed spontaneously. There were no 
late complications of the bile duct. Temporary 
drainage of ascites was severe only in a 19 year 
TABLE II.-RESULTS FOR PATIENTS WITH TRISEGMENTECTOMIES FOR METASTASES WITH FOLLOW.UPSTUDY 
TO 1 APRIL. 1979 
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old woman with an unusually small liver frag-
ment (24,. 
In surviving patients, regeneratiQn, as judged 
by serial scans, was complete or nearly complete 
in two or three months, with two exceptions. One 
patient, in whom about 90 per cent of the liver 
was excised, never had complete restoration of 
hepatic mass, although liver function became 
normal (24). Another patient had an angio-
sarcoma in a liver made severely cirrhotic by 
Thorotrast, thorium dioxide, injections 25 years 
previously. He died more than two months post-
operatively with multiple metastases in the frag-
ment. The residual tissue had little evidence of 
regeneration. This had been reflected in nonres-
olution of postoperative hepatic insufficiency. 
LATE RESULTS 
Benign disease. The four patients recovered 
completely and have no complaints or hepatic 
function abnormalities after four to eight and 
one-half years (Table I). 
Primary hepatic malignant lesion. The results 
are summarized in Table I. Of the 19 patients, 
12 or 63 per cent are alive with follow-up periods 
of two months to five and one-half years. The six 
late deaths occurred two to 47 months postopera-
tively (Table I). All of the late deaths were 
caused by, or contributed to by, recurrent malig-
nant tumor. 
A better idea of the tumor control rate was ob-
tained by analyzing the t 3 patients treated a year 
or longer ago for a primary hepatic malignant 
growth (Tables I and III). A tumor-free state at 
one year connoted a favorable prognosis for long 
term subsequent survival. Six of the 13 patients 
are dead. Three died after two, four and one-half 
and t 2 months. Although the other three patients 
were alive for 19,33 and 47 months, the presence 
of metastases was known by the end of the first 
postoperative year in all but the patient who sur-
vived for 33 months. Seven of the 13 patients are 
still alive. Six of these seven patients have no 
evidence of recurrence after follow-up periods of 
66, 47, 42, 41, 21 and 13 months. The seventh 
patient is alive with metastatic hepatoma which 
was diagnosed one year postoperatively and which 
has been responsive to adriamycin therapy. 
Foster (9) and others have noted that the long 
term results from hepatectomy are better in chil-
dren than in adults. The breakdown of pediatric 
versus adult patients treated a year or longer ago 
for a primary hepatic malignant condition is 
given in Table III. Five of six children are still 
alive, and four are tumor-free after follow-up 
periods of three and one-half to five and one-half 
years. All six were given postoperative chemo-
therapy with agents summarized in Table IV for 
these as well as other pediatric patients. In con-
trast. only two of seven adults treated a year or 
longer ago are stiU alive and tumor-free but with 
shorter follow-up periods. The administration of 
'j 
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TABLE III.-ADULTS VERSUS CHILDREN. PRIMARY 
MALIGNANT CONDITIONS TREATED ONE YEAR OR 
LONGER WITH FOLLOW.UP STUDY TO 1 APRIL. 1979. 
No. 
Pediatric. . . . .• ,- I (19) 
Adult ••..••.•• 7t 
No adjuvant 
therapy ••. 4 2 (2. 33) 
Ali ... 
willi Ali .... 
lumor tumtw·fru 
1(21) 4 (66.47.42.41) 
o 2(13.21 ) 
Adjuvant 
therapy •.. 3 3(4M.12.47) 0 0 
-;p;; hqIe __ ... _ All ..... ~"K 
tD_~ __ -~--"D­
...a-iIIacy-. r..-iII ........... ___ 
chemotherapy to the adults did not seem to have 
an effect on the outcome (Table III). 
Metastases. Two of the seven patients with 
localized hepatic metastases are clinically tumor-
free after nine and S2 months (Table II). The 
former is an adult and the latter a child. Two 
more are alive with metastases. one patient after 
six and the other after 41 months (Table II). 
This last patient had an abdominoperineal resec-
tion 18 months before hepatic trisegmentectomy. 
Eight months after hepatic resection. the right 
lower lobe of othe lung was removed for localized 
metastases. 
As with primary hepatic tumors. the presencc 
or absence of· tumor was usually apparent at one 
year. Recurrence did not preclude long term sur-
vival. 
DISCUSSION 
The general use of trisegmentectomy was dis-
couraged by the high mortality recorded by Bmn-
schwig (3) and others in an earlier time. As a 
consequencc. large series were not reported ex-
cept by Pack and associates (21 ) including Miller 
TABLE IV.-TRISEGMENTECTOMY IN CHILDREN WITH 
FOLLOW·UP STUDY TO 1 APRIL. 1979 
..... Dt.pON Suruiwi Adjvuant IIInGfJIY 
16 
A __ 
so_ N_ 
9 Hepatoma 66_ CytOUn. vincriltinc. SoFUI 
S Hepatoma Dicd19_- CytOUn. vincriltinc. Soru 
2 Neuroblut_ S2_ CytOUn. vincriltine. 
CCNUI. adriamycin. 
3.100 rads 
12 5_.' 4'_ CytOUn. vinc:riRine, Soru 
12 Sa.-.. 42_ CytOUn, vincriltine. 
acti_ycin.OTlCI, 
adriamycin , Hepatoma 41_ CytolWl, vincrillinc. s·re 
IS Hepatoma 21-.t CytOUn. vi.n.une. Soru. 
adriamycin 
IS HepalOlna 3m-. CytOUn. vi.n.une, Sore. 
adriamycin 
·M ..... _ 
t~ "1C.:r"'"OC 10 Mriantycia. t=s-K~Kffi_ 
DT1C,D ........ 
(18) at the Sloan-Kettering Institute, New 
York. They had acquired experience with 42 tri-
segmentectomies by the early 1970's. The largest 
recent collection was also reported from the same 
institution by Fortner and co-authors (7) who 
had reduced the mortality to 14.2 per cent in a 
more recent series consisting of 22 patients. 
However, the potential dangers of the procedure 
were emphasized by the 38 per cent mortality in 
13 instances described by Almenj6 and col-
leagues (1), as recently as 1976. Hemorrhage 
was the main cause of death . 
The experience recorded herein establishes 
that right trisegmentectomy can be perf'ormed 
safely. The operative mortality was 3.3 per cent 
in a series of 30 patients that included many 
highly unfavorable lesions and older patients. 
Special hepatic compression clamps were not 
used, since they limit the extent of resection, nor 
were the isolation and perfusion techniques pre-
viously used by Fortner and associates (7) but 
subscquendy abandoned by them (8). 
The only operative death in our series was 
caused, at least partly, by postoperative thrombo-
sis of a celiac axis that had been studied with 
selective angiography before surgical operation. 
This complication, as well as other less serious 
ones, has dampened our previously expressed 
enthusiasm (23) for preoperative arteriography. 
We still obtain such studies in about 20 per cent 
of the candidates Cor liver resection but only to an-
swer specific questions of tumor localization not 
resolved by noninvasive methods, such as ultra-
sonography and computerized axial tomography. 
The safety of right trisegmentectomy has made 
it reasonable to use this procedure to treat non-
malignant lesions, such as giant adenomas. How-
ever, the question oC its effectiveness in control-
ling malignant tumon still remains. The results 
so far have been encouraging. 
More than SO per cent oC the patients with 
primary hepatic: malignant growths were thought 
to be free of tumor after one year, and of these, 
only one patient subsequently had metastases 
develop. The good prognostic implication of a 
one year tumor-free state has been noted by Fos-
ter (9) and Lin (15) after less extensive resec-
tions. The one year follow-up period was equally 
decisive in patients with loc:aJized liver metas-
tases. The early and late control rate after triseg-
mentectomy for mewtases was somewhat less 
than that reported by Foster (to) and Wilson 
and Adson (28) in patients with generally less 
advanced and consequendy less radically resect-
ed hepatic mcta.stasCI. 
..... p" .... -... '" ~K ...... ~ • • • ~ ..' .-.' • ~ 
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The role, if any, of adjuvant chemotherapy 
and local irradiation in these results could not be 
determined. The tumors were wide ranging in 
cell type. The adjuvant treatment varied in its 
timing and consistency. Finally, the numbers of 
untreated potential control patients were small 
and too often selected out for nontreatment by 
advanced age or infirmity. Long tenn survival 
was obtained without, as well as with, chemo-
therapy. 
Nevertheless, a case for adjuvant chemother-
apy can be made. As reviewed by Foster (9) and 
Lee (14), hepatomas and other primary hepatic 
tumors were considered, until recently, to be non-
responsive to antitumor drugs. The results of 
recent reports have been less pessimistic about 
individual and multiple agents. Moertel (19) 
and Kennedy and associates ( 13) reported that a 
significant number of patients with non resectable 
hepatomas responded to 5-fluorouracil, a claim 
not supported by Link and co-workers (16) and 
numerous earlier workers. In contrast, adria-
mycin has been said to be variably effective for 
surgically untreatable hepatomas by Olweny 
(20), Ihde (12), Vogel (26) and Baker (2) and 
their associates. In the study done by Olweny and 
colleagues (20), the results in a Ugandan pop-
ulation were better than those in the United 
States. 
Treatment with cyclophosphamide, vincris-
tine and 5-Auorouracil as an adjuvant to resec-
tion for hepatoblastoma was advocated by Hol-
ton and co-authors (11) in 1975. The treatment 
of many of our patients, of whom most had hepa-
tomas, followed their protocol. Cochrane and as-
sociates (5) showed that such treatment plus 
methotrexate gave a survival advantage to pa-
tients with hepatoma for whom surgical resection 
was not possible; irradiation of the liver was of no 
value. The addition of adriamycin to the treat-
ment of Holton ( 11 ) and Cochrane (5) and their 
co-workers should be considered in future pa-
tients. The concept that minimal residual disease 
can thereby be controlled after hepatic resection 
will have to be tested with rigid protocols and ap-
propriate controls. 
The possible value of multimodality therapy 
was particularly evident in the eight pediatric 
patients of our trisegmentectomy series. Seven 
are alive. The one death occurred after 19 months. 
Another patient who was operated upon 21 
months ago has recurrences which are highly re-
sponsive to adriamycin treatment. Six of the eight 
patients are clinically tumor-free. Five of these 
six have follow-up periods of three and one-half 
to five and one-half years; the trisegmentectomy 
in the sixth patient was done only three months 
ago. 
SUMMARY 
Thirty patients had right trisegmentectomy for 
19 primary hepatic malignant tumors, seven local-
ized liver metastases and four benign lesions. A 
technical refinement that aided resection of bulky 
posterior and superior tumors was intrahepatic 
:dentification and control of the right hepatic 
vein. The operative mortality was 3.3 per cent. 
Late hepatic insufficiency was not observed. 
More than one-half of the patients operated 
upon a year or more ago for primary hepatic 
malignant growths had a tumor-free state at the 
12 month follow-up period. Beyond this time, 
there was only one recurrence. The results in 
children were twice as good as in adults. The re-
sults in treating localized liver metastases from 
distant primary sites were inferior to those in 
treating primary hepatic tumors. A hypothetical 
case was made for combining hepatic resection 
with adjuvant chemotherapy, even though our 
experience could not be construed as direct sup-
port for this practice. 
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